Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.76 USD | -1.03% | -4.50% | +0.13% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.13% | 438M | |
+58.60% | 59.34B | |
+43.17% | 40.24B | |
-5.12% | 39.88B | |
-5.56% | 28.55B | |
+15.57% | 27.26B | |
-21.23% | 19.23B | |
+33.35% | 12.61B | |
+2.84% | 12.49B | |
+26.76% | 12.28B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- B. Riley Lowers Frequency Therapeutics' PT to $10 from $17 to Reflect FX-322 Late-Stage Study Execution Timelines, OpEx Spend Trajectory; Keeps Buy Rating